pantoprazole

Pantoprazole (BY1023) is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.

Pantoprazole sodium (Pantecta) is the sodium salt form of a substituted benzimidazole with proton pump inhibitor activity. Pantoprazole sodium is a lipophilic, weak base that crosses the parietal cell membrane and enters the acidic parietal cell canaliculus where it becomes protonated, producing the active metabolite sulfenamide, which forms an irreversible covalent bond with two sites of the H+/K+-ATPase enzyme located on the gastric parietal cell, thereby inhibiting both basal and stimulated gastric acid production.

(R)-(+)-Pantoprazole ((R)-(+)-BY1023) sodium is a proton pump inhibitor used in the study of esophageal erosion and ulcers.

Pantoprazole sulfide is a metabolite of the gastric H+/K+ ATPase pump inhibitor pantoprazole . Pantoprazole is metabolized by the cytochrome P450 (CYP) isomers CYP2C19 and CYP3A4 to form pantoprazole sulfide.

S-Pantoprazole (sodium trihydrate), a variant of Pantoprazole, is pivotal in managing diseases associated with gastric acid secretion disorders, serving as a proton pump inhibitor [1].

O-Desmethyl pantoprazole o-sulfate-d3 is the deuterium-labeled version of O-Desmethyl pantoprazole o-sulfate.

N3-Methyl pantoprazole is an impurity of Pantoprazole.

Pantoprazoleimpurity 1 is an impurity associated with Pantoprazole.

Pantoprazole Sodium Hydrate (BY1023 (sodium hydrate)) is a proton pump inhibitor drug, used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.

Pantoprazole-D8 is a deuterium-labeled version of Pantoprazole. Pantoprazole (T6928) (BY1023) is an orally active, potent proton pump inhibitor (PPI). As a substituted benzimidazole, Pantoprazole (T6928) effectively inhibits H+/K+-ATPase with an IC50 of 6.8 μM. It enhances pH stability and possesses antisecretory and anti-ulcer properties. When combined with Doxorubicin, Pantoprazole (T6928) significantly extends tumor growth delay.

Pantoprazole sulfone is a metabolite of the gastric H+/K+ ATPase pump inhibitor pantoprazole . Pantoprazole is metabolized by the cytochrome P450 (CYP) isoforms CYP2C19 and CYP3A4 to form pantoprazole sulfone.

Pantoprazole-D6 is a deuterated compound of Pantoprazole. Pantoprazole (T6928) has a CAS number of 102625-70-7. Pantoprazole (T6928) is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.

Pantoprazole-[D6] Sodium Salt (Standard) is a reference standard of Pantoprazole-[D6] Sodium Salt intended for quantitative analysis, quality control, and related biochemical research applications.

Pantoprazole Sulfone-[D6] (Standard) is a reference standard of Pantoprazole Sulfone-[D6] intended for quantitative analysis, quality control, and related biochemical research applications.